ANZCA Primary interactive diagrams
117 interactive teaching figures mapped to 87 ANZCA Primary learning objectives. Each diagram opens inside the matching note in PRIMEX.
Section d01
Compliance (static, dynamic and specific) and relate this to the elastic properties of the lung
-
Lung + chest wall compliance (Campbell diagram) — Define compliance (static, dynamic and specific) and relate this to the elastic properties of the lung
Elastic properties of the chest wall and plot pressure-volume relationships of the lung, chest wall
-
Lung + chest wall compliance (Campbell diagram) — Describe the elastic properties of the chest wall and plot pressure-volume relationships of the lung, chest wall and the total respiratory system
Pulmonary volumes and their measurement
-
BT_PO 1.20 Lung volumes & capacitiesLung volumes & capacities — Describe lung volumes and capacities, their measurement and normal values
Dead space - anatomical, alveolar and physiological
-
BT_PO 1.21 Oxygen cascade — atmosphere to mitochondrionOxygen cascade — atmosphere to mitochondrion — Describe dead space, its measurement and apply the Bohr equation and alveolar gas equation
Pulmonary ventilation and its measurement
-
BT_PO 1.22 Oxygen cascade — atmosphere to mitochondrionOxygen cascade — atmosphere to mitochondrion — Describe the composition of ideal alveolar and mixed expired gases
Normal ventilation-perfusion matching
-
BT_PO 1.26 V/Q distribution (West / Riley)V/Q distribution (West / Riley) — Describe normal ventilation-perfusion matching
West’s zones of the lung
-
BT_PO 1.27 V/Q distribution (West / Riley)V/Q distribution (West / Riley) — Describe West’s zones of the lung
Shunt equation
-
V/Q distribution (West / Riley) + Oxygen cascade — atmosphere to mitochondrion — Describe the shunt equation
Regional ventilation-perfusion inequalities and abnormalities, venous admixture, and the effect on oxygenation
-
BT_PO 1.29 V/Q distribution (West / Riley)V/Q distribution (West / Riley) — Discuss regional ventilation-perfusion inequalities and abnormalities, venous admixture, and the effect on oxygenation and carbon dioxide elimination
Solubility and diffusion of gases in liquids
-
BT_PO 1.23 Oxygen cascade — atmosphere to mitochondrionOxygen cascade — atmosphere to mitochondrion — Describe the oxygen cascade
Gas exchange across the alveolus, transport of oxygen and CO2 in blood
-
BT_PO 1.24 Oxygen cascade — atmosphere to mitochondrionOxygen cascade — atmosphere to mitochondrion — Describe the alveolar exchange of oxygen and carbon dioxide
Oxygen-haemoglobin dissociation curve
-
Oxyhaemoglobin dissociation curve + Oxygen cascade — atmosphere to mitochondrion — Discuss the carriage of oxygen in blood, the oxyhaemoglobin dissociation curve, oxygen stores in the blood and their clinical significance and implications
Carbon dioxide transport in blood and the Haldane effect
-
BT_PO 1.32 CO₂ dissociation curve (Haldane effect)CO₂ dissociation curve (Haldane effect) — Discuss the carriage of carbon dioxide in blood, the carbon dioxide dissociation curve and their clinical significance and implications
Physiological consequences of intermittent positive pressure ventilation and positive end-expiratory pressure
-
BT_PO 1.35 Mechanical ventilation modesMechanical ventilation modes — Discuss the physiological consequences of intermittent positive pressure ventilation and positive end-expiratory pressure
Different modes of mechanical ventilation and their physiological consequences
-
BT_AM 1.19 Mechanical ventilation modesMechanical ventilation modes — Describe different modes of mechanical ventilation and their physiological consequences
Section d02
Anatomy of the heart, great vessels, and coronary circulation
-
BT_PO 1.42 ECG — coronary territoriesECG — coronary territories — Describe the anatomy of the heart including the coronary circulation and territories supplied
Cardiac action potentials, pacemaker potentials, ionic basis, ECG
-
Wiggers diagram — cardiac cycle (animated) + Cardiac action potential — Describe the physiological basis of electrical activity and its relationship to mechanical events including the: • Ionic basis of automaticity • The normal and abnormal processes of cardiac excitation • Physiological bas…
Physiology of cardiac muscle and the mechanism of excitation contraction coupling
-
BT_PO 1.44 Cardiac action potentialCardiac action potential — Describe the physiology of cardiac muscle and the mechanism of excitation contraction coupling
Events of the cardiac cycle using a Wiggers diagram and pressure-volume loop
-
Ventricular pressure-volume loop + PV loop — valve lesions — Describe the events of the cardiac cycle using a Wiggers diagram and pressure-volume loop
Control of cardiac output including venous return
-
Frank-Starling curve + PV loop — valve lesions — Discuss the factors that determine and control cardiac output and the implications for clinical practice including: • Preload, afterload and contractility • The Frank-Starling mechanism • Cardiac output and vascular func…
Cardiovascular responses to: Changes in posture, Exercise, Valsalva manoeuvre, Positive pressure ventilation
-
BT_PO 1.48 Mechanical ventilation modesMechanical ventilation modes — Discuss the cardiovascular responses to: • Changes in posture • Exercise • Valsalva manoeuvre • Positive pressure ventilation and PEEP • Pneumoperitoneum • Haemorrhage and hypovolaemia • Surgery and trauma
Oxygen delivery, consumption and the oxygen flux equation
-
BT_RT 1.4 Oxygen delivery & consumption (DO₂/VO₂)Oxygen delivery & consumption (DO₂/VO₂) — Describe oxygen delivery and outline the use of indicators of tissue oxygenation (base deficit, lactate, mixed venous oxygen saturation) in resuscitation
Physiological and pharmacological basis of classifying antiarrhythmic agents
-
BT_PO 1.56 Cardiac action potentialCardiac action potential — Outline the physiological and pharmacological basis of classifying antiarrhythmic agents
Pharmacology of • Glyceryl trinitrate • Sodium nitroprusside Outline the pharmacology of other antihypertensive agents
-
BT_PO 1.58 Renin-angiotensin-aldosterone systemRenin-angiotensin-aldosterone system — Describe the pharmacology of • Glyceryl trinitrate • Sodium nitroprusside Outline the pharmacology of other antihypertensive agents
Pharmacology of antianginal agents
-
BT_PO 1.59 ECG — coronary territoriesECG — coronary territories — Outline the pharmacology of drugs used to manage myocardial ischaemia/infarction
Pharmacology of drugs used in cardiac failure
-
Nephron + diuretic sites + Renin-angiotensin-aldosterone system — Outline the pharmacology of drugs used to manage acute or chronic cardiac failure
Section d03
Functional anatomy of the nephron
-
BT_PO 1.61 Nephron + diuretic sitesNephron + diuretic sites — Outline the functional anatomy of the nephron
Physiology of renal blood flow
-
Renal autoregulation (RBF + GFR vs MAP) + Renin-angiotensin-aldosterone system + Acute kidney injury staging — Explain the physiology of renal blood flow
Glomerular filtration and tubular function
-
Starling capillary forces + Nephron + diuretic sites + Acute kidney injury staging — Describe glomerular filtration and tubular function
Mechanisms involved in the regulation of renal function
-
Renal autoregulation (RBF + GFR vs MAP) + Nephron + diuretic sites + Renin-angiotensin-aldosterone system + Acute kidney injury staging — Explain the mechanisms involved in the regulation of renal function
Endocrine functions of the kidney
-
BT_PO 1.66 Nephron + diuretic sites + Renin-angiotensin-aldosterone system + Acute kidney injury stagingNephron + diuretic sites + Renin-angiotensin-aldosterone system + Acute kidney injury staging — Outline the endocrine functions of the kidney
Principles of measurement of glomerular filtration rate and renal blood flow
-
BT_PO 1.68 Starling capillary forces + Renal autoregulation (RBF + GFR vs MAP) + Acute kidney injury stagingStarling capillary forces + Renal autoregulation (RBF + GFR vs MAP) + Acute kidney injury staging — Describe the principles of measurement of glomerular filtration rate and renal blood flow
Physiological effects and clinical assessment of renal dysfunction
-
BT_PO 1.69 Acute kidney injury stagingAcute kidney injury staging — Describe the physiological effects and clinical assessment of renal dysfunction
Renal responses to hypovolaemia
-
Renin-angiotensin-aldosterone system + Acute kidney injury staging — Explain the renal responses to hypovolaemia
Diuretics based on their site of action
-
BT_PO 1.81 Nephron + diuretic sitesNephron + diuretic sites — Classify diuretics based on their site of action
Pharmacology of diuretics
-
BT_PO 1.82 Nephron + diuretic sitesNephron + diuretic sites — Outline the pharmacology of diuretics
Function, distribution and physiological importance of sodium, chloride, potassium, magnesium, calcium
-
Sodium & water disorders + IV fluid composition — Describe the function, distribution and physiological importance of sodium, chloride, potassium, magnesium, calcium and phosphate ions
Mechanisms involved in the maintenance of fluid and electrolyte balance
-
Renin-angiotensin-aldosterone system + Sodium & water disorders + IV fluid composition — Describe the mechanisms involved in the maintenance of fluid and electrolyte balance
Regulation of osmolality
-
Renin-angiotensin-aldosterone system + Sodium & water disorders + IV fluid composition — Describe the regulation of osmolality
Transcapillary fluid exchange and Starling forces
-
BT_PO 1.77 Starling capillary forcesStarling capillary forces — Outline the significance of oncotic pressure, colloid osmotic pressure and reflection coefficients
Body fluid ‘compartments’ and the movement of fluid between compartments
-
BT_PO 1.77a Sodium & water disorders + IV fluid compositionSodium & water disorders + IV fluid composition — Describe the body fluid ‘compartments’ and the movement of fluid between compartments
Intravenous fluids including crystalloids and colloids
-
BT_PO 1.77b Sodium & water disorders + IV fluid compositionSodium & water disorders + IV fluid composition — Describe the chemical composition of crystalloids and colloids, and their use as volume replacement and maintenance fluid, including potential adverse effects
Regulation of acid/base balance
-
Davenport acid-base diagram + Anion gap and delta ratio + ABG interpretation algorithm — Describe the regulation of acid/base balance
Acid-base chemistry using the Henderson-Hasselbach equation and strong ion difference
-
Davenport acid-base diagram + Anion gap and delta ratio + ABG interpretation algorithm — Describe acid-base chemistry using the Henderson- Hasselbach equation and strong ion difference
Section d04
Pharmacology of autonomic nervous system drugs: parasympatholytics
-
BT_PO 1.52 Vasopressor & inotrope selectorVasopressor & inotrope selector — Describe the mechanism of action and effects of sympathomimetic and anticholinergic drugs
Clinically important drug interactions with the autonomic nervous system (e.g
-
Psychotropic receptor profiles & dopamine pathways — Outline clinically important drug interactions with the autonomic nervous system (e.g. tricyclic antidepressants, monoamine oxidase inhibitors)
Management of shock, describe the pharmacology of vasopressors and inotropes
-
BT_RT 1.17 Vasopressor & inotrope selectorVasopressor & inotrope selector — With reference to the management of shock, describe the pharmacology of vasopressors and inotropes
Factors determining intracranial pressure and its regulation
-
BT_RT 1.12 Monro-Kellie intracranial volume + ICP curveMonro-Kellie intracranial volume + ICP curve — Discuss the factors determining intracranial pressure and its regulation
Regulation of cerebral blood flow, and factors leading to loss of autoregulation
-
Cerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) — Describe the regulation of cerebral blood flow, and factors leading to loss of autoregulation
Cerebral perfusion pressure
-
BT_RT 1.14 Cerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curveCerebral autoregulation (CBF vs MAP / PaCO₂ / PaO₂) + Monro-Kellie intracranial volume + ICP curve — Describe cerebral perfusion pressure
Pharmacology of drugs acting via effects on serotonin or serotonin receptors
-
Psychotropic receptor profiles & dopamine pathways — Outline the pharmacology of drugs acting via effects on serotonin or serotonin receptors
Adverse effects of neuromuscular blocking agents and factors that may modify responses to muscle relaxants
-
BT_GS 1.38 Train-of-four monitoringTrain-of-four monitoring — Describe the adverse effects of neuromuscular blocking agents and factors that may modify responses to muscle relaxants
Section d05
Endocrine function of the pancreas and control of blood glucose
-
BT_PO 1.85 Glucose homeostasisGlucose homeostasis — Explain the control of blood glucose
Thyroid hormones and their control
-
BT_PO 1.87 Hypothalamic-pituitary-adrenal axisHypothalamic-pituitary-adrenal axis — Outline control of secretion and the functions of: • Pituitary hormones • Thyroid hormones • Adrenocortical hormones • Adrenomedullary hormones
Pharmacology of insulin and oral hypoglycaemic agents
-
BT_PO 1.90 Glucose homeostasisGlucose homeostasis — Outline the pharmacology of: • Insulin preparations • Oral hypoglycaemics
Pharmacology of thyroid and antithyroid drugs
-
Hypothalamic-pituitary-adrenal axis + Glucose homeostasis — Outline the pharmacology of: • Thyroid hormone replacement and anti- thyroid drugs • Corticosteroids • Glucagon • Vasopressin and analogues
Section d06
Red blood cells and oxygen carrying
-
BT_PO 1.110 Iron homeostasisIron homeostasis — Describe the physiological consequences of acute and chronic anaemia, including iron deficiency.
Physiology of haemostasis, including: Coagulation, The role of platelets, Fibrinolysis
-
BT_PO 1.112 Coagulation cascadeCoagulation cascade — Describe the physiology of haemostasis, including: • Coagulation • The role of platelets • Fibrinolysis
Methods for assessing coagulation, platelet function and fibrinolysis
-
BT_PO 1.114 Coagulation cascadeCoagulation cascade — Describe the methods for assessing coagulation, platelet function and fibrinolysis
Pharmacology of heparin and low molecular weight heparins including their side-effects
-
BT_PO 1.118 Coagulation cascadeCoagulation cascade — Describe the pharmacology of heparin and low molecular weight heparins including their side-effects
Pharmacology of warfarin and other anticoagulant drugs
-
BT_PO 1.120 Coagulation cascadeCoagulation cascade — Describe the pharmacology of warfarin and other anticoagulant drugs
Methods to reverse the effect of warfarin and other anticoagulant drugs
-
BT_PO 1.121 Coagulation cascadeCoagulation cascade — Describe methods to reverse the effect of warfarin and other anticoagulant drugs
Pharmacology of iron replacement
-
BT_PO 1.124a Iron homeostasisIron homeostasis — Outline the pharmacology of iron replacement
Immunology and pathophysiology of hypersensitivity reactions
-
BT_PO 1.128 Complement cascade & hypersensitivity I–IVComplement cascade & hypersensitivity I–IV — Describe the immunology and pathophysiology of hypersensitivity reactions
Immunology and pathophysiology of anaphylaxis
-
Complement cascade & hypersensitivity I–IV — Describe the immunology and pathophysiology of anaphylaxis.
Pharmacology of antimicrobial drugs used perioperatively, including their spectrum of activity
-
BT_PO 1.130 Antimicrobial PK/PD targetsAntimicrobial PK/PD targets — Describe the pharmacology of antimicrobial drugs used perioperatively, including their spectrum of activity.
Section d08
Pharmacodynamics: dose-response relationships, efficacy, potency
-
BT_GS 1.3 Dose-response curvesDose-response curves — Define and explain dose-effect relationships of drugs with reference to: • Graded and quantal response • Therapeutic index • Potency and efficacy • Competitive and non-competitive antagonists • Partial agonists, mixed ag…
Efficacy and potency with reference to dose-response curves
-
BT_GS 1.4 Dose-response curvesDose-response curves — Describe efficacy and potency with reference to dose-response curves
Concept of pharmacokinetic modelling of single and multiple compartment models and define: Half life, Clearance
-
BT_GS 1.7 PK compartment modelsPK compartment models — Explain the concept of pharmacokinetic modelling of single and multiple compartment models and define: • Half life • Clearance • Zero and first order kinetics • Volume of distribution • Bio-availability • Area under the …
Drug absorption with reference to clinically utilised routes of administration
-
BT_GS 1.8 Concentration–time curves & steady stateConcentration–time curves & steady state — Describe drug absorption with reference to clinically utilised routes of administration
Mechanisms of drug clearance and how physiological and pathological disturbance may affect these
-
BT_GS 1.10 Concentration–time curves & steady stateConcentration–time curves & steady state — Describe the mechanisms of drug clearance and how physiological and pathological disturbance may affect these
Mechanisms of non-hepatic and hepatic metabolism of drugs including: Phase 1 and phase 2 reactions
-
BT_GS 1.11 CYP450 inducer / inhibitor mapCYP450 inducer / inhibitor map — Describe the mechanisms of non-hepatic and hepatic metabolism of drugs including: • Phase 1 and phase 2 reactions • Hepatic extraction ratio and its significance • First pass effect • Enzyme induction and inhibition
Pharmacokinetics: absorption, distribution, metabolism, excretion
-
BT_GS 1.12 Context-sensitive half-time + PK compartment models + Concentration–time curves & steady stateContext-sensitive half-time + PK compartment models + Concentration–time curves & steady state — Explain and describe the clinical application of concepts related to intravenous and infusion kinetics including: • Effect-site and effect-site equilibration time • Concept of context sensitive half time • Calculation of…
Mechanisms of drug interactions
-
BT_GS 1.19 CYP450 inducer / inhibitor mapCYP450 inducer / inhibitor map — Describe the mechanisms of drug interactions
Section d09
Uptake and distribution of inhalational anaesthetic agents
-
BT_GS 1.24 Inhalational agent FA/FI uptakeInhalational agent FA/FI uptake — Describe the uptake, distribution and elimination of inhalational anaesthetic agents and the factors which influence induction and recovery from inhalational anaesthesia including the: • Concepts of partition coefficient…
Pharmacokinetics of IV anaesthetic and sedative agents, including: Onset and offset
-
BT_GS 1.30 PK compartment modelsPK compartment models — Discuss the pharmacokinetics of IV anaesthetic and sedative agents, including: • Onset and offset • Clinical implications of differences between drugs
Similarities and differences between commonly used Target Controlled Infusion (TCI) models
-
Context-sensitive half-time + PK compartment models — Outline the similarities and differences between commonly used Target Controlled Infusion (TCI) models
Section d11
Anatomy of the vertebral column, spinal cord
-
BT_RA 1.4 Dermatomes & myotomesDermatomes & myotomes — Describe the anatomy of the vertebral column, spinal cord and meninges relevant to the performance of central neuraxial block with appropriate surface markings.
Section d12
Dermatomal innervations
-
BT_RA 1.5 Dermatomes & myotomesDermatomes & myotomes — Outline the dermatomal innervations
Myotomal innervations
-
BT_RA 1.6 Dermatomes & myotomesDermatomes & myotomes — Outline the myotomal innervations
Actions of agonists, partial agonists, mixed agonist-antagonists and antagonists
-
BT_PM 1.14 Dose-response curvesDose-response curves — Describe the actions of agonists, partial agonists, mixed agonist-antagonists and antagonists
Section d13
Capnography
-
BT_SQ 1.6 Capnography waveform interpreterCapnography waveform interpreter — Describe the methods of measurement applicable to anaesthesia, including clinical utility, complications and sources of error in particular: • SI units • Measurement of volumes, flows, and pressures, including transducer…
Concept of depth of neuromuscular blockade and explain the use of neuromuscular monitoring
-
BT_GS 1.55 Train-of-four monitoringTrain-of-four monitoring — Describe the concept of depth of neuromuscular blockade and explain the use of neuromuscular monitoring
Principles and safe operation of vaporisers
-
BT_SQ 1.12 Desflurane Tec 6 vaporiserDesflurane Tec 6 vaporiser — Describe the principles and safe operation of vaporisers
Principles of the anaesthesia machine and breathing systems
-
Mapleson breathing systems (A-F) + Self-inflating (AMBU) bag-valve-mask — Describe and classify breathing systems used in anaesthesia and resuscitation. Evaluate their clinical utility and hazards associated with their use
Section d14
Glucose homeostasis in the neonate and explain the changes that occur with growth and development
-
SS_PA 1.26 Glucose homeostasisGlucose homeostasis — Outline glucose homeostasis in the neonate and explain the changes that occur with growth and development
Additional diagrams
-
BT_PO 1.111 Iron homeostasisIron homeostasis
PRIMEX
Open these diagrams inside ANZCA Primary
The diagrams above are interactive — they live inside the per-learning-objective notes in PRIMEX. The full ANZCA Primary curriculum, MCQ library, AI-graded SAQ and viva practice are bundled in the same subscription.
Start 7-day free trial